Showing results (11-20 of 295) with videos related to
Sort By:
Pageof 30
Current Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Strategies for treating cancers caused by multiple genome abnormalities: from concepts to cures?Paul WorkmanCancer Chemotherapy and Pharmacology|June 24, 2003
The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperonesPaul WorkmanCancer Research|October 2, 2023
The NCI-60 Human Tumor Cell Line Screen: A Catalyst for Progressive Evolution of Models for Discovery and Development of Cancer DrugsPaul WorkmanAdvances in Experimental Medicine and Biology|September 23, 2020
Correction to: Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal PerspectivePaul WorkmanAdvances in Cancer Research|July 25, 2006
Inhibitors of the HSP90 molecular chaperone: current statusSwee Sharp, Paul WorkmanAdvances in Cancer Research|December 13, 2006
Pharmacodynamic biomarkers for molecular cancer therapeuticsDebashis Sarker, Paul WorkmanCancer Cell|July 12, 2017
Choose and Use Your Chemical Probe Wisely to Explore Cancer BiologyJulian Blagg, Paul WorkmanExpert Opinion on Biological Therapy|January 5, 2002
HSP90 as a new therapeutic target for cancer therapy: the story unfoldsAlison Maloney, Paul WorkmanClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
Hsp90 molecular chaperone inhibitors: are we there yet?Len Neckers, Paul WorkmanAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
PI3 Kinase in Cancer: From Biology to ClinicPaul Workman, Paul ClarkePageof 30